Clinical Lung Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2293498, encodeId=eb372293498c0, content=想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:44:34 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2293491, encodeId=4510229349172, content=请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:25:54 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207550, encodeId=f963220e55014, content=五, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7f9055715, createdName=ms4000001179104614, createdTime=Thu May 30 23:16:25 CST 2024, time=2024-05-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=)]

2025-12-16 ms1000001332961788 来自江西省

想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？

13 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2293498, encodeId=eb372293498c0, content=想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:44:34 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2293491, encodeId=4510229349172, content=请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:25:54 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207550, encodeId=f963220e55014, content=五, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7f9055715, createdName=ms4000001179104614, createdTime=Thu May 30 23:16:25 CST 2024, time=2024-05-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=)]

2025-12-16 ms1000001332961788 来自江西省

请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？

0 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2293498, encodeId=eb372293498c0, content=想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:44:34 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2293491, encodeId=4510229349172, content=请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:25:54 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207550, encodeId=f963220e55014, content=五, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7f9055715, createdName=ms4000001179104614, createdTime=Thu May 30 23:16:25 CST 2024, time=2024-05-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=)]

2023-11-04 ms5000001427749260 来自上海

请问，clinical practice points是啥呀，这个部分应该写什么内容

0 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2293498, encodeId=eb372293498c0, content=想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:44:34 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2293491, encodeId=4510229349172, content=请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:25:54 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207550, encodeId=f963220e55014, content=五, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7f9055715, createdName=ms4000001179104614, createdTime=Thu May 30 23:16:25 CST 2024, time=2024-05-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=)]

2024-05-30 ms4000001179104614 来自江苏省

五

148 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2293498, encodeId=eb372293498c0, content=想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:44:34 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2293491, encodeId=4510229349172, content=请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:25:54 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207550, encodeId=f963220e55014, content=五, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7f9055715, createdName=ms4000001179104614, createdTime=Thu May 30 23:16:25 CST 2024, time=2024-05-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=)]

2022-02-28 ms7000000117561646

偏重的研究方向：肿瘤
经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。

205 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2293498, encodeId=eb372293498c0, content=想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:44:34 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2293491, encodeId=4510229349172, content=请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:25:54 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207550, encodeId=f963220e55014, content=五, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7f9055715, createdName=ms4000001179104614, createdTime=Thu May 30 23:16:25 CST 2024, time=2024-05-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=)]

2022-12-03 ms5000000916595472 来自浙江省

前辈们，为什么我attach files那里一直通过不了？我已经都上传啦

204 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2293498, encodeId=eb372293498c0, content=想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:44:34 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2293491, encodeId=4510229349172, content=请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:25:54 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207550, encodeId=f963220e55014, content=五, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7f9055715, createdName=ms4000001179104614, createdTime=Thu May 30 23:16:25 CST 2024, time=2024-05-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=)]

2022-11-10 14699180m53暂无昵称

接受纯数据库的临床预后文章吗

218 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2293498, encodeId=eb372293498c0, content=想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:44:34 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2293491, encodeId=4510229349172, content=请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:25:54 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207550, encodeId=f963220e55014, content=五, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7f9055715, createdName=ms4000001179104614, createdTime=Thu May 30 23:16:25 CST 2024, time=2024-05-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=)]

2019-11-14 slxbjmu

亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表::
第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表:
第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！

jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！

339 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2293498, encodeId=eb372293498c0, content=想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:44:34 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2293491, encodeId=4510229349172, content=请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:25:54 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207550, encodeId=f963220e55014, content=五, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7f9055715, createdName=ms4000001179104614, createdTime=Thu May 30 23:16:25 CST 2024, time=2024-05-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=)]

2019-10-21 jokese

第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！

337 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2293498, encodeId=eb372293498c0, content=想问一下前辈们，送外审后被编辑拒了，申诉有戏嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:44:34 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2293491, encodeId=4510229349172, content=请问一下前辈们，送外审以后被编辑拒了，申诉有用嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd009895358, createdName=ms1000001332961788, createdTime=Tue Dec 16 21:25:54 CST 2025, time=2025-12-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2166641, encodeId=7480216664169, content=请问，clinical practice points是啥呀，这个部分应该写什么内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dbd8832256, createdName=ms5000001427749260, createdTime=Sat Nov 04 14:13:11 CST 2023, time=2023-11-04, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207550, encodeId=f963220e55014, content=五, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7f9055715, createdName=ms4000001179104614, createdTime=Thu May 30 23:16:25 CST 2024, time=2024-05-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1198092, encodeId=67b1119809227, content=偏重的研究方向：肿瘤 经验分享：太慢了！with editor1个月2周才送审，现在已经送审3个月2周了，不知道何时返修，现在只求不被拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Mon Feb 28 17:19:54 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104084, encodeId=4e4f210408460, content=前辈们，为什么我attach files那里一直通过不了？我已经都上传啦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=204, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86708391618, createdName=ms5000000916595472, createdTime=Sat Dec 03 14:48:03 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2099599, encodeId=abde2099599c4, content=接受纯数据库的临床预后文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef0a5151491, createdName=14699180m53暂无昵称, createdTime=Thu Nov 10 12:10:52 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579880, encodeId=33c35e98804e, content=亲，有一项Review Preference写三名reviewer是随便填写吗，谢谢您jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！jokese 2019-10-21 00:00:00 发表: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=jokese 2019-10-21 发表:: 第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04cb4888094, createdName=slxbjmu, createdTime=Thu Nov 14 00:00:00 CST 2019, time=2019-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578240, encodeId=a5625e82407c, content=第一次投这个，竟然中了，说一下历程，喜欢对后人有帮助！整个过程花了5个月，一审大概3个月，然后直接小修，一个月后叫语言润色，照办后，再一个月就accept了，总体感觉速度有点慢，但是审稿人还是比较友好的！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/04/b0ee45d24186d13687168b7a241aebb7.jpg, createdBy=fe0f2054616, createdName=jokese, createdTime=Mon Oct 21 00:00:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223460, encodeId=cd3a12234602a, content=偏重的研究方向：肺癌;肿瘤 经验分享：请问这个杂志接收case report么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:23:37 CST 2022, time=2022-05-30, status=1, ipAttribution=)]

2022-05-30 钮祜禄

偏重的研究方向：肺癌;肿瘤
经验分享：请问这个杂志接收case report么

218 4 举报

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务